X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
defibrotide (349) 349
humans (193) 193
male (160) 160
hematology (135) 135
index medicus (113) 113
female (109) 109
transplantation (106) 106
bone-marrow-transplantation (97) 97
polydeoxyribonucleotides - therapeutic use (83) 83
veno-occlusive disease (83) 83
liver (81) 81
adult (75) 75
animals (73) 73
polydeoxyribonucleotides - pharmacology (70) 70
oncology (67) 67
middle aged (66) 66
sinusoidal obstruction syndrome (65) 65
immunology (62) 62
hepatic veno-occlusive disease - etiology (60) 60
stem-cell transplantation (60) 60
hematopoietic stem cells (58) 58
hematopoietic stem cell transplantation - adverse effects (55) 55
fibrinolytic agents - therapeutic use (54) 54
pharmacology & pharmacy (53) 53
hematopoietic stem cell transplantation (52) 52
hepatic veno-occlusive disease - drug therapy (52) 52
adolescent (51) 51
hepatic venoocclusive disease (51) 51
children (47) 47
child (46) 46
stem cells (45) 45
risk factors (43) 43
diagnosis (42) 42
aged (41) 41
treatment outcome (41) 41
child, preschool (39) 39
fibrinolytic agents - pharmacology (38) 38
prophylaxis (34) 34
pediatrics (32) 32
infant (31) 31
prostacyclin (31) 31
retrospective studies (31) 31
significant toxicity (31) 31
chemotherapy (30) 30
risk-factors (30) 30
hepatic veno-occlusive disease (29) 29
peripheral vascular disease (29) 29
blood (28) 28
polydeoxyribonucleotides - administration & dosage (28) 28
stem cell transplantation (28) 28
rats (27) 27
therapy (27) 27
fibrinolysis (26) 26
hepatic veno-occlusive disease - diagnosis (26) 26
prevention (26) 26
rabbits (26) 26
venoocclusive disease (26) 26
health aspects (25) 25
high-risk population (25) 25
compassionate-use (24) 24
care and treatment (23) 23
complications and side effects (23) 23
reperfusion (23) 23
analysis (20) 20
bone marrow (20) 20
endothelium (20) 20
hematology, oncology and palliative medicine (20) 20
hepatic veno-occlusive disease - prevention & control (20) 20
liver diseases (20) 20
transplantation, homologous (20) 20
endothelium, vascular - drug effects (19) 19
european-society (19) 19
hepatic veno-occlusive disease - therapy (19) 19
young adult (19) 19
cohort (18) 18
endothelial-cells (18) 18
fibrinolytic agents - administration & dosage (18) 18
heparin (18) 18
platelet aggregation inhibitors - therapeutic use (18) 18
vod (18) 18
bone-marrow transplantation (17) 17
hepatic veno-occlusive disease - chemically induced (17) 17
in vitro techniques (17) 17
incidence (17) 17
mortality (17) 17
surgery (17) 17
transplants & implants (17) 17
trial (17) 17
dose-response relationship, drug (16) 16
hepatic veno-occlusive disease - pathology (16) 16
occlusive disease (16) 16
survival analysis (16) 16
failure (15) 15
research (15) 15
cancer (14) 14
hepatic veno-occlusive disease - mortality (14) 14
time factors (14) 14
toxicity (14) 14
medicine & public health (13) 13
medicine, research & experimental (13) 13
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (354) 354
Italian (6) 6
French (4) 4
Spanish (3) 3
German (2) 2
Czech (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, ISSN 1077-4114, 08/2019, Volume 41, Issue 6, pp. E395 - E401
Severe veno-occlusive disease (VOD) following hematopoietic stem cell transplantation has a high mortality rate. The clinical course of VOD, role of preemptive... 
RISK-FACTORS | BONE-MARROW-TRANSPLANTATION | PHASE-3 | EUROPEAN-SOCIETY | DEFIBROTIDE | PROPHYLAXIS | ONCOLOGY | supportive care | LIVER | hematopoietic stem cell transplantation | PEDIATRICS | SYNDROME/VENO-OCCLUSIVE DISEASE | HEMATOLOGY | veno-occlusive disease | BLOOD
Journal Article
International journal of hematologic oncology, ISSN 2045-1393, 04/2019, Volume 8, Issue 2, p. IJH15
Antonio Pagliuca is Professor of hematopoietic stem cell transplantation at King’s College London (UK) and medical director at King’s College Hospital where,... 
defibrotide | stem cell transplant | veno-occlusive disease | Transplants & implants | Disease | Leukemia | Mortality | Biomarkers | Lymphomas | Patients
Journal Article
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, ISSN 1304-0855, 04/2019, Volume 17, Issue 2, pp. 214 - 221
Objectives: Veno-occlusive disease after liver trans plant has been sporadically reported, and significant uncertainty exists concerning the best treatment and... 
Retransplantation | BONE-MARROW-TRANSPLANTATION | Defibrotide | INJURY | Sinusoidal obstruction syndrome | EUROPEAN-SOCIETY | Endothelium | TRANSPLANTATION | PROPHYLAXIS | INTRAHEPATIC PORTOSYSTEMIC SHUNT | Immunosup pression | SYNDROME/VENO-OCCLUSIVE DISEASE | STEM-CELL TRANSPLANTATION | BLOOD
Journal Article
Redox Biology, ISSN 2213-2317, 04/2019, Volume 22, p. 101117
Hepatic sinusoidal obstruction syndrome (HSOS) is a rare liver disease with considerable morbidity and mortality. (-)-Epicatechin (EPI) is a natural flavonol.... 
NFκB | Nrf2 | (-)-Epicatechin | Monocrotaline | HSOS | PROTECTION | VENOOCCLUSIVE DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | INVOLVEMENT | DEFIBROTIDE | SIGNALING PATHWAY | FLAVANOL (-)-EPICATECHIN | HEME OXYGENASE-1 | STEM-CELL TRANSPLANTATION | NF kappa B
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 01/2019, Volume 25, Issue 1, pp. 137 - 144
Hepatic veno-occlusive disease (VOD), or sinusoidal obstruction syndrome (SOS), is a serious complication of hematopoietic stem cell transplantation (HSCT)... 
Veno-occlusive disease | Sinusoidal obstruction syndrome | VOD | Tacrolimus | SOS | Defibrotide | ADULT PATIENTS | GEMTUZUMAB OZOGAMICIN | RISK-FACTORS | BONE-MARROW-TRANSPLANTATION | IMMUNOLOGY | TRANSPLANTATION | PROPHYLAXIS | URSODEOXYCHOLIC ACID | DISEASE | LIVER | HEMATOLOGY
Journal Article
Oncotarget, ISSN 1949-2553, 12/2018, Volume 9, Issue 96, pp. 36830 - 36832
Malignant mesothelioma is a highly aggressive form of cancer with poor prognosis due to lack of markers for early diagnosis and resistance to conventional... 
Therapies | Heparanase | Mesothelioma | Defbrotide | PG545
Journal Article
BMC Gastroenterology, ISSN 1471-230X, 10/2018, Volume 18, Issue 1, pp. 156 - 7
BackgroundHepatic veno-occlusive disease (HVOD) caused by Gynura segetum has been increasingly reported in China in recent years. The aim of this retrospective... 
Gynura segetum | Prognostic factor | Anticoagulant | Transjugular intrahepatic portosystemic shunt | Hepatic veno-occlusive disease | DIAGNOSIS | BONE-MARROW-TRANSPLANTATION | PYRROLIZIDINE ALKALOIDS | DEFIBROTIDE | SINUSOIDAL OBSTRUCTION SYNDROME | INTRAHEPATIC PORTOSYSTEMIC SHUNT | LIVER | STEM-CELL TRANSPLANTATION | GASTROENTEROLOGY & HEPATOLOGY | Prognosis | Humans | Middle Aged | Risk Factors | Anticoagulants - therapeutic use | Male | Survival Rate | Hepatic Veno-Occlusive Disease - blood | Hepatic Veno-Occlusive Disease - complications | Hepatic Veno-Occlusive Disease - therapy | Hepatic Veno-Occlusive Disease - chemically induced | Young Adult | Bilirubin - blood | Portasystemic Shunt, Surgical | Adolescent | Aged, 80 and over | Adult | Female | Hepatic Encephalopathy - etiology | Aged | Retrospective Studies | Drugs, Chinese Herbal - adverse effects | Serum Albumin - metabolism | Care and treatment | Liver diseases | Analysis | Anticoagulants (Medicine) | Dosage and administration | Research | Compositae | Biological markers | Health risk assessment | Risk factors | Hypertension | Anticoagulants | Transplants & implants | Laboratories | Liver | Albumin | Bilirubin | Survival | Patients | Clinical outcomes | Veno-occlusive disease | Studies | Survival analysis | Chemotherapy | Encephalopathy | Medical prognosis | Stem cells | Diuretics | Bone marrow | Drug dosages | Hepatic encephalopathy | Veins & arteries
Journal Article